APOB and hyperlipidemia: Consistent with our hypothesis, by establishing a naringenin-target-hyperlipidemia network and inferring a positive causal relationship determined by genetics, we concluded that naringenin can affect LM and treat hyperlipidemia through APOB regulation, and this regulation is likely to have an inhibitory effect.